Product Information

WELLBUTRIN XL 300 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $92.4068 per EA under NDC 00187073130. Its NADAC has been published 619 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the bupropion hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

WELLBUTRIN XL 300 MG TABLET

bupropion hydrochloride
$92.4068per EA
High Outlier

Strength

300 mg/1

NDC

00187073130

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

9/17/2025

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA021515

On Market Since

8/29/2003

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for WELLBUTRIN XL 300 MG TABLET has been published 619 times since Nov 28, 2013, and over the history we have for it it has risen 623.6%. The table below summarizes its recorded NADAC range and movement.

Current price$92.4068 per EA
All-time high$92.6526 (May 14, 2025)
All-time low$12.7707 (Nov 28, 2013)
52-week high$92.4068
52-week low$92.2300
Median price$57.3459
Average price$58.9597
Largest weekly change+20.9% (Oct 8, 2014)
Weeks tracked619
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.2%

3Y

+20.9%

5Y

+38.1%

All

+623.6%

Generic Alternatives

The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of WELLBUTRIN XL 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for WELLBUTRIN XL 300 MG TABLET, manufactured by Bausch Health US LLC, is $92.4068 per EA (NDC 00187073130), effective Oct 1, 2025.

How has the price of WELLBUTRIN XL 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for WELLBUTRIN XL 300 MG TABLET has risen 623.6%. It has been tracked across 619 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for WELLBUTRIN XL 300 MG TABLET?

Since Nov 28, 2013, the NADAC for WELLBUTRIN XL 300 MG TABLET has ranged from a low of $12.7707 (Nov 28, 2013) to a high of $92.6526 (May 14, 2025), with a median of $57.3459 per EA.

Are there cheaper alternatives to WELLBUTRIN XL 300 MG TABLET?

Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUPROPION HCL XL 300 MG TABLET, is $0.1115 per EA — about 100% below WELLBUTRIN XL 300 MG TABLET.

Who manufactures WELLBUTRIN XL 300 MG TABLET?

WELLBUTRIN XL 300 MG TABLET (NDC 00187073130) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.